Adzospas 40 Injection
By Adzospas
Rx
2ml Injection in a Ampoule

Composition
Drotaverine(40mg)

Manufacturer - ADZO Lifesciences Pvt Ltd
GF31, Lotus Plaza Market Vaibhav Khand Indirapuram Ghaziabad - 201014 (INDIA)

Expires on or after
June, 2026

liver
Limited information is available on the safety of Adzospas 40 Injection in individuals with liver disease. It is important to consult with your doctor regarding the use of this medication if you have liver issues. Your healthcare provider can provide personalized guidance based on your specific health condition.

kidney
Limited information is known about the use of Adzospas 40 Injection in kidney disease patients. It is advised to consult your doctor before use.

alcohol
Consult your doctor when consuming alcohol with Adzospas 40 Injection.

driving
Adzospas 40 Injection may cause vertigo, affecting driving ability. Use caution when driving after taking Adzospas 40 Injection.

pregnancy
Information about the safety of using Adzospas 40 Injection during pregnancy is not provided. It is recommended to consult with your doctor before considering the use of this medication.

breastfeeding
It is better to consult your doctor before using Adzospas 40 Injection during breastfeeding.
| Habit Forming | No |
| Chemical Class | Papaverine Derivatives |
| Therapeutic Class | GASTRO INTESTINAL |
| Action Class | Phosphodiesterase-IV inhibitors (Smooth Muscle Relaxant) |
₹27
₹30
10% OFF
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025
